Literature DB >> 15321742

Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

Atsunori Saraya1, Masaaki Yokokura, Tohru Gonoi, Susumu Seino.   

Abstract

Although fluoroquinolones are used widely in the treatment of various infectious diseases, some of the drugs are known to cause hypoglycemia as a side-effect. We have investigated the effects of three fluoroquinolone derivatives, levofloxacin, gatifloxacin, and temafloxacin, on insulin secretion and pancreatic beta-cell ATP-sensitive K(+) channel (K(ATP) channel) activity. While levofloxacin had only a small effect on insulin secretion and K(ATP) currents, gatifloxacin and temafloxacin stimulated insulin secretion and inhibited K(ATP) channel currents in a dose-dependent manner. We also determined the site of action of gatifloxacin and temafloxacin on the K(ATP) channel. In a reconstituted system, gatifloxacin and temafloxacin inhibited Kir6.2 Delta C26 channels, which function in the absence of the SUR subunit, indicating direct action of the drugs on the Kir6.2 subunits. These results suggest that stimulation of insulin secretion by inhibition of pancreatic beta-cell K(ATP) channels underlies the hypoglycemia caused by certain fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321742     DOI: 10.1016/j.ejphar.2004.06.032

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

Review 1.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

Review 2.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 3.  Drug-induced hypoglycaemia: an update.

Authors:  Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

4.  Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.

Authors:  A Szollosi; M Nenquin; J C Henquin
Journal:  Br J Pharmacol       Date:  2010-01-28       Impact factor: 8.739

Review 5.  Dysglycaemias and fluoroquinolones.

Authors:  Roshan J Lewis; John F Mohr
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient.

Authors:  Ambar Khaira; Ankur Gupta; Nikhil Tandon; Sanjay K Agarwal
Journal:  Clin Exp Nephrol       Date:  2008-07-17       Impact factor: 2.801

7.  Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Kaitlin E Kennedy; Chengwen Teng; Taylor M Patek; Christopher R Frei
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

8.  Hypoglycemia revisited in the acute care setting.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Chin-Wang Hsu; Chien-Sheng Cheng; Der-Ming Chu
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

Review 9.  Chemical Aspects of Human and Environmental Overload with Fluorine.

Authors:  Jianlin Han; Loránd Kiss; Haibo Mei; Attila Márió Remete; Maja Ponikvar-Svet; Daniel Mark Sedgwick; Raquel Roman; Santos Fustero; Hiroki Moriwaki; Vadim A Soloshonok
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

10.  Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia.

Authors:  S Vallurupalli; G Huesmann; J Gregory; M G Jakoby
Journal:  Diabet Med       Date:  2008-07       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.